Fetal Valproate Syndrome (FVS)

2008 ◽  
Vol 36 (4) ◽  
pp. 361-369 ◽  
Author(s):  
Arnold L. Christianson ◽  
Nicole Chester ◽  
Jennifer G. R. Kromberg

1987 ◽  
Vol 111 (2) ◽  
pp. 308-309 ◽  
Author(s):  
Guy Massa ◽  
Dominique Lecoutere ◽  
Paul Casaer

2018 ◽  
Vol 1 (1) ◽  

Background: Fetal Valproate Syndrome (FVS) results from prenatal exposure to valproic acid (VPA). Case characteristics: A four year old female child presented with facial dysmorphism and features of autism spectrum disorder (ASD). She had in-utero exposure to valproic acid (VPA). Message: VPA to be avoided in pregnancy and in Dysmorphism or ASD children maternal anti- convulsant drug history must be taken.


2013 ◽  
Vol 9 (4) ◽  
pp. 165-166
Author(s):  
Charles Smith

1995 ◽  
Vol 32 (9) ◽  
pp. 724-727 ◽  
Author(s):  
J Clayton-Smith ◽  
D Donnai

2014 ◽  
Vol 20 (2) ◽  
pp. 187 ◽  
Author(s):  
ParmarthG Chandane ◽  
Ira Shah

2017 ◽  
Vol 163 (5) ◽  
pp. 605-607
Author(s):  
E. A. Ivanova ◽  
I. G. Kapitsa ◽  
N. N. Zolotov ◽  
V. F. Pozdnev ◽  
T. A. Voronina

Sign in / Sign up

Export Citation Format

Share Document